Imagine
The potential of medical innovation is limitless. If Europe fully seizes this opportunity, just imagine what we could achieve
LEARN MOREHow can we ensure Europeans don't miss out on the latest advances in treatment?
EFPIA Code of Practice and relationships with patient organisations and healthcare professionals.
Latest Updates
VIEW ALL-
EFPIA News 26.04.24
Journal article - Evolving assessment pathways for precision oncology medicines to improve patient access:...
This study describes challenges in assessing PO and TA medicines, explores possible solutions, and provides actionable recommendations to facilitate an...
Read Article -
EFPIA News 26.04.24
White paper on circular economy
Continued adoption of circular economy principles into the pharmaceutical sector can reduce materials extraction and operational waste, contribute to a...
Read Article -
Statements & press releases 25.04.24
Critical Medicines Alliance: A positive collaboration to enhance medicines supply chain security and...
EFPIA will work within the Alliance to help build resilience through a number of recommendations
Read Article -
Partner Event 15.05.24
12th European Conference on Rare Disease & Orphan Products
The ECRD is the largest, patient-led, rare disease policy-shaping event held in Europe.
View Event -
Partner Event 31.05.24
IMI impact on antimicrobial resistance
Combatting antimicrobial resistance: the legacy of the IMI COMBACTE projects.
View Event -
EFPIA Event 04.06.24
Countdown to the EU HTA: how can we seize this opportunity to improve patient access to medicines?
In January 2025, all new cancer medicines and advanced therapy medicinal products (ATMPs) will be jointly assessed at the EU level.
View Event